Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 OPN -Revisited.

Literature DB >> 26266236

OPN -Revisited.

Vijayanirmala Subraman¹, Muthukumar Thiyagarajan², N Malathi³, Sharada T Rajan⁴.

Abstract

Osteopontin (OPN), a matrix extracellular glyco-phosphoprotein is found in various tissues such as epithelium lined tissues, kidney, bone and teeth .It is also detected in all body fluids including blood and breast milk. OPN plays role in a number of physiological and pathologic events such as cell adhesion, migration and cell survival, angiogenesis, apoptosis, inflammation and wound healing. This review summarizes the current data of the biological activities of OPN in the development of tumour, its progression and metastasis.

Entities: Disease Gene

Keywords: Angiogenesis; Cell adhesion; Metastasis; Osteopontin

Year: 2015 PMID： 26266236 PMCID： PMC4525627 DOI： 10.7860/JCDR/2015/12872.6111

Source DB: PubMed Journal: J Clin Diagn Res ISSN： 0973-709X

40 in total

1. Co-expression of osteopontin and CD44v9 in gastric cancer.

Authors: T Ue; H Yokozaki; Y Kitadai; S Yamamoto; W Yasui; T Ishikawa; E Tahara
Journal: Int J Cancer Date: 1998-04-17 Impact factor: 7.396

2. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.

Authors: Angela Celetti; Domenico Testa; Stefania Staibano; Francesco Merolla; Valentina Guarino; Maria Domenica Castellone; Renata Iovine; Gelsomina Mansueto; Pasquale Somma; Gaetano De Rosa; Vieri Galli; Rosa Marina Melillo; Massimo Santoro
Journal: Clin Cancer Res Date: 2005-11-15 Impact factor: 12.531

3. Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma.

Authors: Kalu U E Ogbureke; Rafik A Abdelsayed; Harvey Kushner; Li Li; Larry W Fisher
Journal: Cancer Date: 2010-04-01 Impact factor: 6.860

4. Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Authors: Jae-Hoon Kim; Steven J Skates; Toshimitsu Uede; Kwong-kwok Wong; John O Schorge; Colleen M Feltmate; Ross S Berkowitz; Daniel W Cramer; Samuel C Mok
Journal: JAMA Date: 2002-04-03 Impact factor: 56.272

5. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.

Authors: Deepak Agrawal; Tingan Chen; Rosalyn Irby; John Quackenbush; Ann F Chambers; Marianna Szabo; Alan Cantor; Domenico Coppola; Timothy J Yeatman
Journal: J Natl Cancer Inst Date: 2002-04-03 Impact factor: 13.506

6. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity.

Authors: R E Devoll; W Li; K V Woods; G J Pinero; W T Butler; M C Farach-Carson; R P Happonen
Journal: J Oral Pathol Med Date: 1999-03 Impact factor: 4.253

7. Osteopontin expression and distribution in human carcinomas.

Authors: L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal: Am J Pathol Date: 1994-09 Impact factor: 4.307

Review 8. Osteopontin: a protein with diverse functions.

Authors: D T Denhardt; X Guo
Journal: FASEB J Date: 1993-12 Impact factor: 5.191

9. Clinical significance of osteopontin expression in T1 and T2 tongue cancers.

Authors: Chih-Yen Chien; Chih-Ying Su; Hui-Ching Chuang; Fu-Min Fang; Hsuan-Ying Huang; Ching-Mei Chen; Chang-Han Chen; Chao-Cheng Huang
Journal: Head Neck Date: 2008-06 Impact factor: 3.147

10. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance].

Authors: Li-Li Zhang; Shu-Li Shao; Yan Wu
Journal: Chin J Cancer Date: 2010-01

25 in total

Review 1. Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors: Andrew J Sawyer; Themis R Kyriakides
Journal: Adv Drug Deliv Rev Date: 2016-01-04 Impact factor: 15.470

2. Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function.

Authors: Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal: Neurol Sci Date: 2017-06-21 Impact factor: 3.307

3. A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.

Authors: Shinji Furuya; Grace A Chappell; Yasuhiro Iwata; Takeki Uehara; Yuki Kato; Hiroshi Kono; Ramon Bataller; Ivan Rusyn
Journal: Toxicol Appl Pharmacol Date: 2016-09-15 Impact factor: 4.219

4. Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome After Aneurysmal Subarachnoid Hemorrhage.

Authors: Yoshinari Nakatsuka; Masato Shiba; Hirofumi Nishikawa; Mio Terashima; Fumihiro Kawakita; Masashi Fujimoto; Hidenori Suzuki
Journal: Mol Neurobiol Date: 2018-01-20 Impact factor: 5.590

5. Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism.

Authors: Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal; Raafat Abdel-Misih
Journal: Endocr Res Date: 2017-09-22 Impact factor: 1.720